Page 7 - Financing Round News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RTW Participates in $95 Million Financing Round in Monte Rosa Therapeutics RTW Venture Fund Limited (the "Company"), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Monte Rosa Therapeutics, Inc. ("Monte Rosa") on 12 March 2021 of its completion of a $95 million Series C financing round. The Company, alongside other investment vehicles of RTW Investments, LP (the "Investment Manager"), confirms that it participated in the financing rou...

RTW Leads $106 Million Financing Round in Tenaya Therapeutics RTW Venture Fund Limited (the "Company"), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Tenaya Therapeutics, Inc. ("Tenaya") on 01 March 2021 of its completion of a $106 million Series C financing round led by RTW Investments, LP (the "Investment Manager"). The Company, alongside other investment vehicles of the Investment Manager, confirms that it participated in the financing round...

RTW Participates in $75 Million Financing Round in Immunocore RTW Venture Fund Limited (the "Company"), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by its portfolio company Immunocore, Ltd ("Immunocore") on 11 January 2021 of its completion of a $75 million Series C financing round. The announcement of the financing round comes following positive Phase 3 trial interim analysis data for tebentafusp in patients with metastatic uveal melanoma that ...

RTW Participates in $56 Million Financing Round in Biomea Fusion RTW Venture Fund Limited (the "Company"), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Biomea Fusion, Inc. ("Biomea") on 06 January 2021 of its completion of a $56 million Series A financing round. The Company, alongside other investment vehicles of RTW Investments, LP (the "Investment Manager"), confirms that it participated in the financing round together with other investment ...